Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REGN | REGENERON PHARMACEUTICALS, INC. | EVP Research and Development | $60.2 M | -$17.4 M | -22.5% | Feb 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|